FDA proposes major shift in blood-donation eligibility guidance
![FDA recommendation](/sites/default/files/styles/900x400/public/2018-07/FDA%20recommendation.jpg?itok=fDH7EYXX)
The Food and Drug Administration is signaling a major shift in federal policy on who may donate blood, proposing guidelines that would eliminate the existing time-based blood donation deferrals for men who have sex with men and women who have sex with those individuals. Instead, FDA is proposing that blood donor eligibility would be assessed using gender-inclusive, individual risk-based questions to reduce the risk of transfusion-transmitted HIV. The policy shift is one that AHA has long advocated for, in part due to the significant strain on the nation’s blood supply in the post-COVID-19 pandemic landscape
Related News Articles
Headline
The Organ Donation and Transplantation Alliance has created new resources for health care providers to encourage more organ donation and transplants. It has…
Headline
The AHA yesterday sent a Special Bulletin to members notifying them of concerns by the American Red Cross, America’s Blood Centers and the Association for the…
Headline
America’s Blood Centers and ADRP, the Association of Blood Donor Professionals, last week released a guide highlighting changes in U.S. blood donation and use…
Headline
The American Red Cross this week announced an emergency blood shortage, urging Americans to donate blood or platelets to alleviate the shortage and ensure…
Headline
The Food and Drug Administration May 11 finalized revised recommendations for assessing blood donor eligibility, which use the same risk-based questions for…
Headline
AHA today applauded and urged the Food and Drug Administration to finalize its draft guidance proposing that blood donor eligibility be determined based…